The 35th CINP World Congress of Neuropsychopharmacology

Presentation information

Print

[CINP2024] Short Communications

CINP2024 » Short Communications

Short Communications 18
Others 1

Sat. May 25, 2024 1:00 PM - 2:15 PM Room 9 (G404)

Chair: Hiroko Kotajima (Tokyo Metropolitan Institute of Medical Science)

[SC18-6] Methoxphenidine, a designer drug or a possible route for research to depression treatment?

*Bronislav Jurásek1, Magdalena Vágnerová1,2, Hana Walaská1, Kristýna Mazochová3, Martin Kuchař1 (1. Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of chemistry and technology in Prague, Prague, Czech Republic, 2. Department of Analytical Chemistry, University of chemistry and technology in Prague, Prague, Czech Republic, 3. Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic)

Keywords:Methoxphenidine, Dissociative anaesthetics, Antidepressant, Pharmacokinetics

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Password